Xiao Zhang Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

4/2022	Association of equol producing status with aortic calcification in middle-aged Japanese men: The ERA JUMP study.
3/2022	Ameliorative effect of scutellarin on acute alcohol brain injury in mice.
10/2021	Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases-From Molecular Mechanisms to Studies in Humans.
3/2021	Independent effects of 2hPG, FPG and HbA1c on cardiovascular risk: Analysis of a nationally representative sample from China.
12/2020	Recent testosterone drop-off and risk of cardiovascular events.
9/2020	Ambient fine particulate matter pollution and years of life lost from cardiovascular diseases in 48 large Chinese cities: Association, effect modification, and additional life gain.
8/2020	Salt-Related Knowledge, Behaviors, and Associated Factors Among Chinese Adults - China, 2015.
1/2020	Ambient ozone pollution and years of life lost: Association, effect modification, and additional life gain from a nationwide analysis in China.
12/2019	Ginsenoside-Rb1 Improved Diabetic Cardiomyopathy through Regulating Calcium Signaling by Alleviating Protein O-GlcNAcylation.
10/2019	Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Zhang Research Topics

Disease

234	Neoplasms (Cancer) 10/2022 - 01/2007
52	Inflammation (Inflammations) 06/2022 - 05/2005
37	Neoplasm Metastasis (Metastasis) 10/2022 - 12/2007
35	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2007
31	Infections 12/2022 - 03/2010
31	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2010
28	Carcinogenesis 02/2022 - 01/2007
23	Stroke (Strokes) 07/2022 - 02/2011
20	Liver Neoplasms (Liver Cancer) 07/2022 - 12/2014
20	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 04/2004
19	Ischemic Stroke 07/2022 - 10/2012
17	Pain (Aches) 01/2021 - 01/2002
15	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 11/2012
15	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2011
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2012
12	Insulin Resistance 09/2022 - 01/2012
12	Rheumatoid Arthritis 01/2021 - 01/2002
11	Adenocarcinoma of Lung 02/2022 - 04/2015
11	Hemorrhage 01/2022 - 08/2013
10	Epstein-Barr Virus Infections 11/2022 - 01/2018
10	COVID-19 09/2022 - 01/2020
10	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 11/2012
10	Neuroinflammatory Diseases 03/2022 - 10/2012
10	Fibrosis (Cirrhosis) 01/2022 - 01/2015
10	Triple Negative Breast Neoplasms 01/2022 - 01/2015
10	Ischemia 12/2020 - 02/2011
9	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022 - 02/2017
9	Hypoxia (Hypoxemia) 01/2022 - 01/2015
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2005
8	Melanoma (Melanoma, Malignant) 10/2022 - 05/2010
8	Parkinson Disease (Parkinson's Disease) 06/2022 - 01/2015
8	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 10/2014
8	Obesity 01/2022 - 01/2011
8	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 05/2012
8	Hypertension (High Blood Pressure) 01/2022 - 05/2009
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 02/2010
8	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 11/2012
8	Hyperalgesia 01/2022 - 03/2012
8	Stomach Neoplasms (Stomach Cancer) 07/2021 - 04/2007
8	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 04/2012
7	Alcoholism (Alcohol Abuse) 09/2022 - 01/2013
7	Osteoporosis 05/2022 - 05/2008
7	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022 - 10/2008
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2022 - 11/2011
7	Starvation 01/2022 - 06/2009
7	Body Weight (Weight, Body) 03/2020 - 01/2011
7	Brain Ischemia (Cerebral Ischemia) 01/2020 - 01/2012
7	Hepatitis E 01/2019 - 12/2005
6	Disease Resistance 01/2022 - 04/2017

Drug/Important Bio-Agent (IBA)

73	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2004
52	Pharmaceutical PreparationsIBA 05/2022 - 11/2009
44	Biomarkers (Surrogate Marker)IBA 09/2022 - 08/2011
30	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2010
23	VaccinesIBA 11/2022 - 05/2014
19	Biological ProductsIBA 07/2022 - 07/2013
18	Long Noncoding RNAIBA 06/2022 - 12/2014
18	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2011
18	Messenger RNA (mRNA)IBA 02/2022 - 01/2007
18	Therapeutic UsesIBA 01/2022 - 10/2012
17	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2011
16	EnzymesIBA 01/2022 - 01/2009
15	heparanaseIBA 01/2022 - 05/2005
14	LipidsIBA 09/2022 - 01/2013
14	Retinaldehyde (Retinal)IBA 01/2022 - 09/2008
13	Small Interfering RNA (siRNA)IBA 11/2020 - 01/2007
12	Transcription Factors (Transcription Factor)IBA 09/2022 - 03/2010
12	Amyloid (Amyloid Fibrils)IBA 03/2022 - 04/2004
12	CytokinesIBA 12/2021 - 03/2010
12	C-Reactive ProteinIBA 11/2021 - 11/2013
12	AntigensIBA 03/2021 - 03/2010
12	Peptides (Polypeptides)IBA 03/2020 - 11/2009
11	AntibodiesIBA 12/2022 - 02/2012
11	AntioxidantsIBA 03/2022 - 02/2011
10	Immunoglobulin G (IgG)IBA 12/2022 - 11/2009
10	InterferonsIBA 01/2022 - 08/2013
10	Heparitin Sulfate (Heparan Sulfate)IBA 02/2015 - 05/2005
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2014
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 01/2007
9	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2011
8	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 07/2017
8	Circular RNAIBA 07/2022 - 01/2018
8	RNA (Ribonucleic Acid)IBA 05/2022 - 12/2005
8	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 06/2004
8	CreatinineIBA 11/2018 - 02/2011
7	CateninsIBA 05/2022 - 10/2014
7	Particulate MatterIBA 04/2022 - 11/2012
7	AnticoagulantsIBA 01/2021 - 10/2016
7	ginsenoside RdIBA 01/2020 - 02/2011
6	Interleukin-6 (Interleukin 6)IBA 05/2022 - 11/2013
6	Monoclonal AntibodiesIBA 04/2022 - 08/2013
6	Immune Checkpoint InhibitorsIBA 03/2022 - 11/2020
6	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2007

Therapy/Procedure

120	Therapeutics 10/2022 - 07/2009
31	Drug Therapy (Chemotherapy) 07/2022 - 09/2012
19	Immunotherapy 05/2022 - 11/2009
13	Radiotherapy 04/2022 - 10/2013
13	Photothermal Therapy 04/2020 - 07/2014
11	Precision Medicine 01/2021 - 07/2014
8	Aftercare (After-Treatment) 03/2021 - 09/2006
6	Length of Stay 01/2022 - 07/2012